Operating Expenses Summary of Novogene Co., Ltd.

Novogene Co., Ltd.'s latest annual operating expenses in 2023 was 640.67 Million CNY , up 193.42% from previous year.
Novogene Co., Ltd.'s latest quarterly operating expenses in 2024 Q3 was 172.02 Million CNY , down -0.81% from previous quarter.
Novogene Co., Ltd. reported a annual operating expenses of 609.44 Million CNY in annual operating expenses 2022, up 12.11% from previous year.
Novogene Co., Ltd. reported a annual operating expenses of 543.62 Million CNY in annual operating expenses 2021, up 18.4% from previous year.
Novogene Co., Ltd. reported a quarterly operating expenses of 168.88 Million CNY for 2024 Q2, up 1.1% from previous quarter.
Novogene Co., Ltd. reported a quarterly operating expenses of 172.02 Million CNY for 2024 Q3, down -0.81% from previous quarter.

Annual Operating Expenses Chart of Novogene Co., Ltd. (2023 - 2015)

Historical Annual Operating Expenses of Novogene Co., Ltd. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	640.67 Million CNY	193.42%
2022	609.44 Million CNY	12.11%
2021	543.62 Million CNY	18.4%
2020	459.14 Million CNY	-2.06%
2019	468.82 Million CNY	38.49%
2018	338.51 Million CNY	34.29%
2017	252.07 Million CNY	46.49%
2016	172.08 Million CNY	30.55%
2015	131.81 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	167.04 Million CNY	-66.84%
2024 Q2	168.88 Million CNY	1.1%
2024 Q3	172.02 Million CNY	-0.81%
2023 Q2	158.3 Million CNY	3.67%
2023 Q3	169.35 Million CNY	6.98%
2023 Q4	503.78 Million CNY	197.48%
2023 Q1	152.7 Million CNY	2.5%
2023 FY	1.78 Billion CNY	193.42%
2022 Q1	140.59 Million CNY	-15.22%
2022 Q4	148.97 Million CNY	-10.13%
2022 Q3	165.76 Million CNY	7.57%
2022 Q2	154.09 Million CNY	9.6%
2022 FY	609.44 Million CNY	12.11%
2021 Q3	151.86 Million CNY	34.5%
2021 FY	543.62 Million CNY	18.4%
2021 Q4	165.83 Million CNY	9.2%
2021 Q2	112.9 Million CNY	-0.1%
2021 Q1	113.02 Million CNY	125.48%
2020 Q3	-776.24 Million CNY	-106.53%
2020 Q2	-375.85 Million CNY	-30.85%
2020 FY	459.14 Million CNY	-2.06%
2020 Q1	-287.22 Million CNY	44.72%
2020 Q4	-443.62 Million CNY	42.85%
2019 Q4	-519.61 Million CNY	27.29%
2019 Q3	-714.62 Million CNY	-1508.54%
2019 Q2	50.73 Million CNY	121.86%
2019 FY	468.82 Million CNY	38.49%
2019 Q1	-232.05 Million CNY	-316.09%
2018 Q1	65.16 Million CNY	0.0%
2018 Q4	107.38 Million CNY	0.0%
2018 FY	338.51 Million CNY	34.29%
2018 Q3	107.38 Million CNY	64.79%
2018 Q2	65.16 Million CNY	0.0%
2017 FY	252.07 Million CNY	46.49%
2016 FY	172.08 Million CNY	30.55%
2015 FY	131.81 Million CNY	0.0%

Peer Operating Expenses Comparison of Novogene Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Beijing Tiantan Biological Products Co., Ltd.	824.72 Million CNY	22.317%
JiangSu WuZhong Pharmaceutical Development Co., Ltd.	614.32 Million CNY	-4.289%
Jinyu Bio-technology Co., Ltd.	630.76 Million CNY	-1.57%
Vcanbio Cell & Gene Engineering Corp., Ltd	953.58 Million CNY	32.814%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	1.38 Billion CNY	53.63%
Zhejiang Ausun Pharmaceutical Co., Ltd.	158.79 Million CNY	-303.472%
DaShenLin Pharmaceutical Group Co., Ltd.	7.17 Billion CNY	91.071%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.	3.13 Billion CNY	79.576%
GuiZhou SanLi Pharmaceutical Co.,Ltd	861.16 Million CNY	25.603%
Pulike Biological Engineering, Inc.	571.28 Million CNY	-12.147%
Beijing Konruns Pharmaceutical Co.,Ltd.	675.67 Million CNY	5.181%
Shanghai Hile Bio-Technology Co., Ltd.	68.54 Million CNY	-834.641%
Qingdao Vland Biotech INC.	431.31 Million CNY	-48.54%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.	422.38 Million CNY	-51.679%
Aurisco Pharmaceutical Co.,Ltd.	375.24 Million CNY	-70.735%
Zhejiang East Asia Pharmaceutical Co., Ltd.	211.78 Million CNY	-202.518%
Hainan Huluwa Pharmaceutical Group Co., Ltd.	860.45 Million CNY	25.542%
Mabwell (Shanghai) Bioscience Co., Ltd.	1.17 Billion CNY	45.662%
Beijing Hotgen Biotech Co., Ltd.	314.19 Million CNY	-103.908%
Assure Tech (Hangzhou) Co., Ltd.	36.27 Million CNY	-1666.024%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.	399.61 Million CNY	-60.323%
Cabio Biotech (Wuhan) Co., Ltd.	106.55 Million CNY	-501.257%
Shanghai Shen Lian Biomedical Corporation	177.43 Million CNY	-261.077%
Nanjing Vazyme Biotech Co., Ltd.	1.01 Billion CNY	36.793%
Shandong Kexing Bioproducts Co,.Ltd	1.12 Billion CNY	42.86%
Shanghai Junshi Biosciences Co., Ltd.	3.21 Billion CNY	80.058%
Shanghai Model Organisms Center, Inc.	182.57 Million CNY	-250.906%
Suzhou Zelgen Biopharmaceuticals Co., Ltd.	710.45 Million CNY	9.822%
Xiamen Amoytop Biotech Co., Ltd.	1.27 Billion CNY	49.808%
Shanghai ZJ Bio-Tech Co., Ltd.	141.69 Million CNY	-352.141%
Chengdu Olymvax Biopharmaceuticals Inc.	461.02 Million CNY	-38.968%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd	545.28 Million CNY	-17.493%
Shanghai Haohai Biological Technology Co., Ltd.	1.45 Billion CNY	55.967%
Jiangsu Bioperfectus Technologies Co., Ltd.	622.73 Million CNY	-2.88%
Jiangsu Aidea Pharmaceutical Co., Ltd.	258.4 Million CNY	-147.934%
Chengdu Easton Biopharmaceuticals Co., Ltd.	652.1 Million CNY	1.754%
Sinocelltech Group Limited	1.77 Billion CNY	63.879%
Wuhan Keqian Biology Co.,Ltd	307.99 Million CNY	-108.014%
Shanghai Allist Pharmaceuticals Co., Ltd.	1.28 Billion CNY	50.05%
Anhui Huaheng Biotechnology Co., Ltd.	274.4 Million CNY	-133.474%
Youcare Pharmaceutical Group Co., Ltd.	2.39 Billion CNY	73.284%
Jiangsu gdk Biotechnology Co., Ltd.	186.4 Million CNY	-243.696%
Beijing Kawin Technology Share-Holding Co., Ltd.	1 Billion CNY	36.497%
Hangzhou Biotest Biotech Co.,Ltd.	105.69 Million CNY	-506.145%

Global Stocks Search

Novogene Co., Ltd. (688315.SS)

Operating Expenses Summary of Novogene Co., Ltd.

Annual Operating Expenses Chart of Novogene Co., Ltd. (2023 - 2015)

Historical Annual Operating Expenses of Novogene Co., Ltd. (2023 - 2015)

Peer Operating Expenses Comparison of Novogene Co., Ltd.